ASMB (ASMB) Stock Price & Analysis
ASMB (ASMB) rose 1.30% to USD 36.6 as of September 8, 2026 at 06:56 UTC, according to Nexqual real-time market data.
ASMB last closed at USD 36.6; the session ranged USD 35.49–36.77 on volume of 156,451 shares. Market capitalization is —, with a 52-week range of USD 20.23–39.71 (NMS). Source: Nexqual, September 8, 2026 at 06:56 UTC.
Key Statistics (as of September 8, 2026 at 06:56 UTC)
| Price | USD 36.6 |
|---|---|
| Change | ▲ 1.30% (up) |
| Previous Close | USD 36.6 |
| Open | USD 36.6 |
| Day Range | USD 35.49 – 36.77 |
| 52-Week Range | USD 20.23 – 39.71 |
| Volume | 156,451 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ASMB)
Nexqual's technical model rates ASMB "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 06:56 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 68.84 (neutral) |
| vs SMA50 | Above (USD 29.18) |
| MACD | 2.26 (positive) |
From ASMB's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | USD 3.71 | ▼ 0.27% |
| ANAB | AnaptysBio, Inc. | USD 56.8 | ▲ 1.72% |
| NXTC | NextCure, Inc. | USD 7.82 | ▲ 6.39% |
| ATRA | Atara Biotherapeutics, Inc. | USD 9.76 | ▲ 3.39% |
| APRE | Aprea Therapeutics, Inc. | USD 0.79 | ▼ 3.13% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:56 UTC. This page is informational and not investment advice.